Predictions for future growth of ESRD prevalence

被引：18

作者：

Briggs, JD ^{[1
]}

Berthoux, F ^{[1
]}

Jones, E ^{[1
]}

机构：

[1] St Thomas Hosp, ERAEDTA Registry Off, London, England

来源：

KIDNEY INTERNATIONAL | 2000年 / 57卷

关键词：

registry; chronic renal failure; renal replacement therapy;

D O I：

10.1046/j.1523-1755.2000.07408.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The European Union (EU) has 15 member countries and a total population of 373 million. In 1995 the incidence of new patients starting renal replacement therapy (RRT) was 120 per million population (pmp). The overall incidence of death was 67 pmp and the total number of patients alive on treatment was 644 pmp. During this year, the pool of patients expanded by 8.2%. These overall figures concealed large differences between countries. For example, the incidence of new patients varied from 69 pmp to 163 pmp, the stock of patients on RRT varied from 444 pmp to 773 pmp and the expansion rate of the pool of RRT patients varied form 2.3% to 13%. On the basis of these figures, it is likely that the stock of patients will continue to increase steadily, but at a slowly diminishing rate, to reach a figure of 1000 pmp by 2001 or 2002.

引用

页码：S46 / S48

页数：3